✦ LIBER ✦

Effects of the dopamine D-1 antagonist SCH 23390 and the D-2 antagonist sulpiride on saline acceptance-rejection in water-deprived rats

✍ Scribed by David B. Gilbert; Steven J. Cooper

Book ID: 113221485
Publisher: Elsevier Science
Year: 1987
Tongue: English
Weight: 370 KB
Volume: 26
Category: Article
ISSN: 0091-3057
DOI: 10.1016/0091-3057(87)90597-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Inhibition of drinking by naltrexone in

Inhibition of drinking by naltrexone in the rat: Interaction with the dopamine D-1 antagonist SCH 23390 and the D-2 antagonist sulpiride

✍ Makoto Ukai; Shinobu Nakayama; Tsutomu Kameyama 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 353 KB

Differential behavioural interactions be

Differential behavioural interactions between the dopamine D-1 antagonist SCH 23390 and the dopamine D-2 antagonists metoclopramide and sulpiride in nonhabituated mice

✍ Christopher J. Chandler; Beryl S. Starr; Michael S. Starr 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 469 KB

Pentazocine-like discriminative stimulus

Pentazocine-like discriminative stimulus effects of morphine are blocked by the dopamine D-1 antagonist SCH23390, but not by the dopamine D-2 antagonist sulpiride

✍ Makoto Ukai; Eiko Hiraiwa; Tsutomu Kameyama 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 261 KB

The D1 dopamine receptor antagonist, SCH

The D1 dopamine receptor antagonist, SCH 23390 reduces locomotor activity and rearing in rats

✍ Diane C. Hoffman; Richard J. Beninger 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 152 KB

Effect of the dopamine D1-like receptor

Effect of the dopamine D1-like receptor antagonist SCH 23390 on the microstructure of ingestive behaviour in water-deprived rats licking for water and NaCl solutions

✍ Adriana Galistu; Paolo S. D'Aquila 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 267 KB

Attenuation of the locomotor-sensitizing

Attenuation of the locomotor-sensitizing effects of the D2 dopamine agonist bromocriptine by either the D1 antagonist SCH 23390 or the D2 antagonist raclopride

✍ Roy A. Wise; William A. Carlezon Jr. 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 525 KB

Injections of the selective D, dopamine agonist bromocriptine (5.0 mg/ kg, IP) produced progressively stronger locomotion over 10 days of repeated testing. Concurrent treatment with either the D, antagonist SCH 23390 (0.01 or 0.1 mg/kg, IP) or the D, antagonist raclopride (0.1 or 1.0 mg/kg, IP) supp